L&G Pharma Breakthrough UCITS ETF

The L&G Pharma Breakthrough ETF invests in a diverse range of pharmaceutical companies that are positioned for significant growth through innovative developments and favorable regulatory environments. By tracking the Solactive Pharma Breakthrough Value Index, the fund focuses on firms within the pharma sector that are expected to achieve breakthroughs in medical treatments and benefit from supportive commercial incentives. This targeted portfolio aims to capture long-term value by selecting companies with strong potential to lead advancements in the pharmaceutical industry.